全文获取类型
收费全文 | 13770篇 |
免费 | 1599篇 |
国内免费 | 76篇 |
专业分类
耳鼻咽喉 | 134篇 |
儿科学 | 388篇 |
妇产科学 | 263篇 |
基础医学 | 2181篇 |
口腔科学 | 291篇 |
临床医学 | 1685篇 |
内科学 | 2509篇 |
皮肤病学 | 265篇 |
神经病学 | 1051篇 |
特种医学 | 479篇 |
外科学 | 1850篇 |
综合类 | 657篇 |
一般理论 | 16篇 |
预防医学 | 1578篇 |
眼科学 | 149篇 |
药学 | 1149篇 |
2篇 | |
中国医学 | 83篇 |
肿瘤学 | 715篇 |
出版年
2022年 | 134篇 |
2021年 | 252篇 |
2020年 | 135篇 |
2019年 | 204篇 |
2018年 | 228篇 |
2017年 | 192篇 |
2016年 | 220篇 |
2015年 | 286篇 |
2014年 | 331篇 |
2013年 | 501篇 |
2012年 | 677篇 |
2011年 | 714篇 |
2010年 | 406篇 |
2009年 | 409篇 |
2008年 | 600篇 |
2007年 | 595篇 |
2006年 | 628篇 |
2005年 | 604篇 |
2004年 | 562篇 |
2003年 | 519篇 |
2002年 | 470篇 |
2001年 | 418篇 |
2000年 | 439篇 |
1999年 | 373篇 |
1998年 | 179篇 |
1997年 | 143篇 |
1996年 | 135篇 |
1995年 | 121篇 |
1994年 | 114篇 |
1993年 | 124篇 |
1992年 | 274篇 |
1991年 | 286篇 |
1990年 | 273篇 |
1989年 | 274篇 |
1988年 | 251篇 |
1987年 | 233篇 |
1986年 | 217篇 |
1985年 | 211篇 |
1984年 | 201篇 |
1983年 | 159篇 |
1982年 | 107篇 |
1981年 | 122篇 |
1980年 | 112篇 |
1979年 | 171篇 |
1978年 | 165篇 |
1977年 | 131篇 |
1976年 | 120篇 |
1975年 | 106篇 |
1974年 | 143篇 |
1973年 | 129篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
M. E. Bougnoux C. Dupont L. Turner E. Rouveix M. Dorra M. H. Nicolas-Chanoine 《European journal of clinical microbiology & infectious diseases》1997,16(8):598-600
The case of a white-heroin addict who developed disseminated candidiasis following coinfection byCandida glabrata andCandida albicans is reported. Genomic random amplified polymorphic DNA typing suggested that theCandida glabrata blood isolates originated in the oral cavity of the patient. This case strengthens the evidence thatCandida species other thanCandida albicans can be involved in the pathogenesis of disseminated candidiasis in heroin addicts. 相似文献
102.
Proteins of Rous sarcoma virus 总被引:32,自引:0,他引:32
103.
To assess the functional capability of human milk lymphocytes, we studied phytohemagglutinin-induced lymphokine production by breast milk and, for comparison, peripheral blood lymphocyte cultures. Two lymphokines, lymphocyte-derived chemotactic factor (LDCF) and immune interferon, were assayed in supernatants of milk and blood lymphocyte cultures obtained from women 2 to 6 days postpartum. Eleven parallel milk and blood samples were studied for LDCF production. In nine experiments, both milk and blood lymphocytes produced LDCF. In the two other experiments, milk cells did not produce LDCF. In 10 milk cultures studied, all produced interferon activity. Acid and heat lability characteristics were typical of immune interferon. These results further characterize milk lymphocytes as immunologically competent and possibly important effector cells in neonatal immunity. 相似文献
104.
105.
106.
Hamvas RM Johnson M Vlieger AM Ling C Sherriff A Wade A Klein NJ Turner MW Webster AD 《Infection and immunity》2005,73(8):5238-5240
Polymorphisms in exon 1 of the MBL-2 gene, resulting in reduced plasma levels of mannose binding lectin, were significantly overrepresented in 23 patients with primary antibody deficiency and culture-proven mycoplasma infections (P = 0.0038). This association persisted with the inclusion of a further nine suspected (doxycycline-responsive) cases (P = 0.0087). The lectin was shown to bind to three strains of mycoplasma. 相似文献
107.
Clinical and cost-effectiveness of a new nurse-led continence service: a randomised controlled trial 总被引:3,自引:0,他引:3 下载免费PDF全文
Kate S Williams R Phil Assassa Nicola J Cooper David A Turner Christine Shaw Keith R Abrams Christopher Mayne Carol Jagger Ruth Matthews Michael Clarke Catherine W McGrother The Leicestershire MRC Incontinence Study Team 《The British journal of general practice》2005,55(518):696-703
BACKGROUND: Continence services in the UK have developed at different rates within differing care models, resulting in scattered and inconsistent services. Consequently, questions remain about the most cost-effective method of delivering these services. AIM: To evaluate the impact of a new service led by a continence nurse practitioner compared with existing primary/secondary care provision for people with urinary incontinence and storage symptoms. DESIGN OF STUDY: Randomised controlled trial with a 3- and 6-month follow-up in men and women (n = 3746) aged 40 years and over living in private households (intervention [n = 2958]; control [n = 788]). SETTING: Leicestershire and Rutland, UK. METHOD: The continence nurse practitioner intervention comprised a continence service provided by specially trained nurses delivering evidence-based interventions using predetermined care pathways. They delivered an 8-week primary intervention package that included advice on diet and fluids; bladder training; pelvic floor awareness and lifestyle advice. The standard care arm comprised access to existing primary care including GP and continence advisory services in the area. Outcome measures were recorded at 3 and 6 months post-randomisation. RESULTS: The percentage of individuals who improved (with at least one symptom alleviated) at 3 months was 59% in the intervention group compared with 48% in the standard care group (difference of 11%, 95% CI = 7 to 16; P<0.001) The percentage of people reporting no symptoms or 'cured' was 25% in the intervention group and 15% in the standard care group (difference of 10%, 95% CI = 6 to 13, P = 0.001). At 6 months the difference was maintained. There was a significant difference in impact scores between the two groups at 3 and 6 months. CONCLUSIONS: The continence nurse practitioner-led intervention reduced the symptoms of incontinence, frequency, urgency and nocturia at 3 and 6 months; impact was reduced; and satisfaction with the new service was high. 相似文献
108.
Monoclonal antibodies against human granulocytes and myeloid differentiation antigens 总被引:4,自引:0,他引:4
Patrice Mannoni Anna Janowska-Wieczorek A. Robert Turner Locksley McGann Jean-Michael Turc 《Human immunology》1982,5(4):309-323
Monoclonal antibodies (MCA) were obtained by immunizing BALB/c mice with 99% pure granulocytes from normal donors or with a whole leukocyte suspension obtained from a chronic myelogenous leukemia (CML) patient, and then fusing the mouse spleen cells with a 315–43 myeloma cell clone. Four MCA were selected and studied using ELISA, immunofluorescence, cytotoxicity assays, and FACS analysis. Antibodies 80H.1. 80H.3. and 80H.5 (from normals) and 81H.1 (from CML) detected antigens expressed on neutrophils. Antibodies 80H.1 and 80H.3 (lgG) also reacted with monocytes but not with other blood cell subsets. Antibodies 80H.5 and 81H.1 (lgM) were cytotoxic and reacted strongly with most of the cells of the neutrophil maturation sequence. i.e., myeloblasts, promyelocytes, myelocytes, and mature granulocytes. Antibodies 80H.5 and 81H.1 also inhibited BFU-GM and CFU-E. Antigens recognized by 80H.3. 80H.5, and 81H.1 were expressed both on a proportion of cells from HL.60, KG.1, ML.1, and K562 myeloid cell lines, and on a proportion of blast cells isolated from patients with acute myelogenous leukemia. They were not found on lymphoid cell lines or lymphoid leukemia cells. These MCA recognize either late differentiation antigens expressed on mature neutrophils and monocytes (80H.1 and 80H.3) or early differentiation antigens (80H.5 and 81H.1) specific to the granulocytic lineage. They may be useful for a better definition of those antigens specific to hematopoietic stem cells and their relationship with normal or neoplastic hematopoiesis. 相似文献
109.
Novel proteins with binding specificity for DNA CTG repeats and RNA CUG repeats: implications for myotonic dystrophy 总被引:7,自引:6,他引:7
While an unstable CTG triplet repeat expansion is responsible for myotonic
dystrophy, the mechanism whereby this genetic defect induces the disease
remains unknown. To detect proteins binding to CTG triplet repeats, we
performed bandshift analysis using as probes double- stranded DNA fragments
having CTG repeats [ds(CTG)6-10] and single- stranded oligonucleotides
having CTG repeats ss(CTG)8 or RNA CUG triplet repeats (CUG)8. The source
of protein was nuclear and cytoplasmic extracts of HeLa cells, fibroblasts
and myotubes. Proteins binding to the double-stranded DNA repeat
[ds(CTG)6-10], were inhibited by nonlabeled ds(CTG)6-10, but not by a
non-specific DNA fragment (USF/AD-ML). Another protein binding to ssCTG
probe and RNA CUG probe was inhibited by nonlabeled (CTG)8 and (CUG)8.
Nonlabeled oligos with different triplet repeat sequences, ss(CAG)8 or
ss(CGG)8, did not inhibit binding to the ss(CTG)8 probe. However, when
labeled as probes, the (CAG)8 and (CGG)8 bound to proteins distinct from
the CTG proteins and binding was inhibited by nonlabeled (CAG)8 or (CGG)8
respectively. The protein binding only to the RNA repeat (CUG)8 was
inhibited by nonlabeled (CUG)8 but not by nonlabeled single- or
double-stranded CTG repeats. Furthermore, the CUG-BP exhibited no binding
to an RNA oligonucleotide of triplet repeats of the same length but having
a different sequence, CGG. The CUG binding protein was localized to the
cytoplasm, whereas dsDNA binding proteins were localized to the nuclear
extract. Thus, several trinucleotide binding proteins exist and their
specificity is determined by the triplet sequence. The novel protein,
CUG-BP, is particularly interesting since it binds to triplet repeats known
to be present in myotonin protein kinase mRNA which is responsible for
myotonic dystrophy.
相似文献
110.
Studies that used the MMPI to predict the response of chronic low back pain patients to standard medical treatment have not produced definitive results. Patients seen in a university hospital orthopedic back pain clinic were given the MMPI before treatment, and 6 to 12 months later 76 patients completed follow-up forms that indicated their level of intensity during the previous week and their ratings of the success of treatment in relieving their pain as well as in enabling them to return to normal activities. Predictions of poor response were made in terms of either single MMPI scales or code types. Patients with poor outcome on two of the three criteria (level of pain intensity and ability to return to normal activities) had significantly higher scores on the Hs scale. The predicted high risk code types very accurately identified patients with poor response on the same two criteria; however, the code-type procedure overpredicted poor response in the good outcome group. 相似文献